In February 2022, Alembic Pharma earned the highest moving annual revenue from its Anti-infective drug formulations Azithral, generating over 2.8 billion Indian rupees. The company's anti-infectives drug Althrocin and respiratory drug Wikoryl followed suite with over 842 million Indian rupees and 765 million Indian rupees respectively during the same time period.
Revenue of Alembic Pharma India in February 2022, by leading therapy drug
(in million Indian rupees)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Motilal Oswal Group. (March 8, 2022). Revenue of Alembic Pharma India in February 2022, by leading therapy drug (in million Indian rupees) [Graph]. In Statista. Retrieved December 31, 2024, from https://www.statista.com/statistics/1097049/india-alembic-pharma-revenue-by-leading-therapy-drugs/
Motilal Oswal Group. "Revenue of Alembic Pharma India in February 2022, by leading therapy drug (in million Indian rupees)." Chart. March 8, 2022. Statista. Accessed December 31, 2024. https://www.statista.com/statistics/1097049/india-alembic-pharma-revenue-by-leading-therapy-drugs/
Motilal Oswal Group. (2022). Revenue of Alembic Pharma India in February 2022, by leading therapy drug (in million Indian rupees). Statista. Statista Inc.. Accessed: December 31, 2024. https://www.statista.com/statistics/1097049/india-alembic-pharma-revenue-by-leading-therapy-drugs/
Motilal Oswal Group. "Revenue of Alembic Pharma India in February 2022, by Leading Therapy Drug (in Million Indian Rupees)." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1097049/india-alembic-pharma-revenue-by-leading-therapy-drugs/
Motilal Oswal Group, Revenue of Alembic Pharma India in February 2022, by leading therapy drug (in million Indian rupees) Statista, https://www.statista.com/statistics/1097049/india-alembic-pharma-revenue-by-leading-therapy-drugs/ (last visited December 31, 2024)
Revenue of Alembic Pharma India in February 2022, by leading therapy drug (in million Indian rupees) [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1097049/india-alembic-pharma-revenue-by-leading-therapy-drugs/
